WFD Ventures logo

WFD Ventures

North America, New York, United States, New York

Description

WFD Ventures is a New York-based venture capital firm specialized in early- and mid-stage, and growth capital investments.

Investor Profile

WFD Ventures has made 8 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (25%)
  • Series C (25%)
  • Private Equity (13%)
  • Series A (13%)
  • Series B (13%)
  • Series E (13%)

Country Focus

  • United States (63%)
  • Norway (38%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical Device
  • Health Care
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does WFD Ventures frequently co-invest with?

New Science Ventures
North America, Connecticut, United States, Greenwich
Co-Investments: 1
MC
North America, California, United States, Palo Alto
Co-Investments: 1
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Morningside Group
North America, Massachusetts, United States, Newton Center
Co-Investments: 1
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 1
Sigma Prime Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
F2 Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Sigma Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Avista Capital Partners
North America, New York, United States, New York
Co-Investments: 3
Gilde Healthcare
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 2

What are some of recent deals done by WFD Ventures?

BionX™ Medical Technologies

Bedford, Massachusetts, United States

BiOM is engaged in developing the PowerFoot One, an ankle-foot device providing active amputees with near-normal gait.

BiotechnologyHealth CarePharmaceutical
Series EDec 23, 2015
Amount Raised: $17,057,767
OptiNose

Oslo, Oslo, Norway

OptiNose develops nasal drug delivery technologies and combined drug and device therapies.

BiotechnologyMedical DevicePharmaceutical
Series COct 6, 2015
Amount Raised: $30,000,000
OptiNose

Oslo, Oslo, Norway

OptiNose develops nasal drug delivery technologies and combined drug and device therapies.

BiotechnologyMedical DevicePharmaceutical
Series CAug 5, 2014
Amount Raised: $35,000,000
BionX™ Medical Technologies

Bedford, Massachusetts, United States

BiOM is engaged in developing the PowerFoot One, an ankle-foot device providing active amputees with near-normal gait.

BiotechnologyHealth CarePharmaceutical
Series DSep 13, 2012
Amount Raised: $17,000,000
ProterixBio

Billerica, Massachusetts, United States

ProterixBio engages in developing innovative products to transform the management of chronic diseases.

BiotechnologyHealth DiagnosticsPharmaceutical
Series DJun 14, 2010
Amount Raised: $25,000,000
OptiNose

Oslo, Oslo, Norway

OptiNose develops nasal drug delivery technologies and combined drug and device therapies.

BiotechnologyMedical DevicePharmaceutical
Private EquityJun 7, 2010
Amount Raised: $48,500,000
BionX™ Medical Technologies

Bedford, Massachusetts, United States

BiOM is engaged in developing the PowerFoot One, an ankle-foot device providing active amputees with near-normal gait.

BiotechnologyHealth CarePharmaceutical
Series BOct 21, 2009
Amount Raised: $20,000,000
ImaCor

Jericho, New York, United States

ImaCor offers ClariTEE probe and Zura imaging system, for hemodynamic management, echocardiography and transesophageal echocardiography.

BiotechnologyHealth CareMedical Device
Series AFeb 21, 2009
Amount Raised: $5,450,000